Latest clinical study News

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Aged Care Study To Test Virus Fighting Technology
More research supports androgen treatment for breast cancer
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
Immutep appoints research institute to conduct first-in-human study of IMP761
Diabetes Australia kicks off partnership with Defeat Diabetes
Dimerix raises $20 million to continue and expand late-stage clinical trial of DMX-200
Pilot Program For Gambling
Biomedical grants set to bring new projects to Queensland
Strongest contender in decades in fight against breast cancer
Vaccine shows promise against CMV, a virus that causes birth defects
Deflexifol clinical data presented at ASCO Gastrointestinal Cancers Symposium
Starpharma says Viraleze shows antiviral efficacy in COVID-19 patients
Microba Life Sciences announces results of successful Phase IBD trial
Orthocell announces final positive results of cell therapy in ‘tennis elbow’ study
AdAlta reports favourable patient tolerability after third dose in AD-214 extension study
Support for heavy gamblers through family intervention
Combination of personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer
Inside AMD study
Adrenocortical carcinoma: No mitotane for low risk of recurrence
Study suggests flu vaccine may take edge off respiratory virus
Multi-million dollar funding boost for BioSpine
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
Medicinal cannabis is a ‘life-changing treatment’ for people with Tourette syndrome
Starpharma announces that Viraleze approved in Malaysia
Pharmaxis reports positive results from trial of PXS‐6302
LBT Innovations begins search for new board chair
Discovery identifies those likely to experience life-threatening dengue fever
Obesity may exacerbate breast cancer risk in women with BRCA mutations
GreenLight Clinical and Cure Therapeutics look to future collaboration
Clinical trial of potential needle-free vaccination for influenza
Less lung tissue removal needed for early stage cancer
New immunotherapy holds promise for ovarian cancer
Study explores possible source of enamel hypomineralisation in children
US recruitment milestone for trial of Immuron’s Travelan
Study hoping to reduce cerebral palsy in preterm infants
Contactless screening tool could revolutionise chronic wound treatment
What are postbiotics and how can they improve our gut health?
Botanix announces positive BTX 1702 clinical study outcome
TGA provisionally approves Moderna bivalent Covid vaccine for use as booster dose in adults
Dimerix confirms CLARITY 2.0 Covid study concludes recruitment
DImerix announces new patient family for DMX-700
Hormonal breast cancer treatment reduces long-term risk of recurrence
Virtual lung therapy by smartphone app rivals traditional method
Hidden toll: examining social costs of long Covid will improve prevention, treatment and care
University of Manchester twins with Ukrainian counterpart